ALFA Filings
Every announcement, straight from the exchange
Every financial results announcement on NSE and BSE that our alert engine sent, newest first.
Time
16,741 announcements
GHCL Ltd reported revenue from operations of ₹790.5 Cr (+1.2% YoY) and net profit of ₹115.6 Cr (-23.1% YoY) for Q4 FY26.
GHCL Limited reported audited financial results for FY26 and recommended a 120% dividend (Rs. 12 per share). The board approved a Rs. 59.52 Crore capital budget and a revenue budget for FY27. Deloitte Haskins & Sells was recommended as new statutory auditors for a five-year term commencing from the 43rd AGM.
Sat Kartar Life Ltd reported revenue from operations of ₹110.6 Cr (+27.0% YoY) and net profit of ₹9.8 Cr (+63.3% YoY) for H2 FY26.
Sat Kartar Life Limited reported consolidated annual revenue of ₹203.12 Crore and net profit of ₹17.10 Crore for FY2026. Standalone revenue reached ₹193.84 Crore. The auditors issued an unmodified opinion, reflecting stable financial reporting and significant year-on-year growth in both top and bottom lines.
Ajanta Pharma Ltd reported revenue from operations of ₹1,422 Cr (+21.5% YoY) and net profit of ₹266.7 Cr (+18.4% YoY) for Q4 FY26.
Ajanta Pharma Ltd reported its FY 2026 financial results, with annual consolidated revenue crossing ₹5,453 Crore and PAT exceeding ₹1,056 Crore. The company achieved 21% quarterly revenue growth and 18% PAT growth. Branded generics across India, Asia, and Africa remains the core business, contributing 68% of total revenue.
Bajaj Auto Ltd reported revenue from operations of ₹1,007 Cr (+118.6% YoY) and net profit of ₹229.8 Cr (+247.7% YoY) for Q4 FY26.
Bajaj Auto Credit Limited approved its audited financial results for FY26, reporting a 98% YoY growth in Asset Under Management to ₹18,835 Crore. Profit After Tax rose significantly to ₹665 Crore from ₹58 Crore. The board also appointed Ms. Khwahish Rawal as Company Secretary and Sharp & Tannan Associates as joint statutory auditors.
Ginni Filaments Ltd reported revenue from operations of ₹90.1 Cr (+0.1% YoY) and net profit of ₹7.1 Cr (+47.9% YoY) for Q4 FY26.
Ginni Filaments Limited reported audited financial results for FY 2025-26, with total income reaching ₹370.53 Crore. Net profit from continuing operations stood at ₹40.97 Crore. The board also approved the re-appointment of M/s AW & Co. as internal auditors for FY 2026-27.
DCW Ltd reported revenue from operations of ₹609.1 Cr (+13.2% YoY) and net profit of ₹18.1 Cr (+60.2% YoY) for Q4 FY26.
DCW Ltd reported audited FY26 results with total income of ₹2,162.67 Crore and net profit of ₹48.17 Crore. The Board recommended a final dividend of ₹0.20 (10%) per share. Additionally, it re-appointed internal and cost auditors for FY27.
Kisan Mouldings Ltd reported revenue from operations of ₹80.6 Cr (-3.2% YoY) and a net loss of ₹3.3 Cr for Q4 FY26.
Kisan Mouldings Ltd reported its FY26 audited financial results and announced significant leadership changes. Mr. Arun Agarwal was appointed Managing Director, replacing Mr. Sanjeev Aggarwal. The company also appointed M/s. AKGVG & Associates as Statutory Auditors to fill a casual vacancy and finalized several other auditor appointments for the upcoming financial year.
Sayaji Industries Ltd reported revenue from operations of ₹267.6 Cr (+8.5% YoY) and net profit of ₹10.6 Cr for Q4 FY26.
Sayaji Industries Ltd approved its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company reported a consolidated net profit of ₹1.50 Crore for FY26. Additionally, the board approved the appointment of new internal and cost auditors for the upcoming financial year.
Emcure Pharmaceuticals reported strong FY26 results with consolidated revenue growing 16.6% YoY to ₹9,203.54 Crore, crossing the $1 billion milestone. Reported PAT rose 33.1% to ₹941 Crore. International markets drove growth, up 22.2%, while domestic sales grew 10%. The Board recommended a final dividend of ₹3.60 per share.
Onward Technologies Ltd reported revenue from operations of ₹137.1 Cr (+7.7% YoY) and net profit of ₹9.6 Cr (-7.7% YoY) for Q4 FY26.
Onward Technologies approved FY26 financial results with consolidated annual revenue of ₹543.85 Crore and recommended a final dividend of ₹8 per share. The Board also approved the re-appointment of four directors, including Executive Chairman Harish Mehta and MD Jigar Mehta, for five-year terms starting May 2026.
Kriti Industries (India) Ltd reported revenue from operations of ₹141.8 Cr (+3.1% YoY) and net profit of ₹4 Cr for Q4 FY26.
Kriti Industries (India) Ltd reported audited financial results for FY26. The board approved the amalgamation of its wholly-owned subsidiary, Kriti Auto & Engineering Plastics, and re-appointed Mr. Shiv Singh Mehta as Chairman and Managing Director for three years. No dividend was recommended for the financial year 2025-26.
Lloyds Engineering Works reported consolidated full-year revenue of ₹1,301.14 Crore, a 54% YoY growth. EBITDA rose 50% to ₹239.07 Crore, while PAT reached ₹197.57 Crore. The company's consolidated order book stands at a strong ₹2,643.39 Crore as of April 1, 2026, providing high revenue visibility for the next 15 months.
Lloyds Engineering Works Ltd reported revenue from operations of ₹495 Cr (+113.4% YoY) and net profit of ₹46.5 Cr (+137.2% YoY) for Q4 FY26.
Lloyds Engineering Works reported consolidated revenue of ₹1301.14 Crore for FY26, a 54% growth. EBITDA rose 50% to ₹239.07 Crore. The Board recommended a 25% final dividend (₹0.25 per share). Consolidated order book stands at ₹2,643.39 Crore, providing strong revenue visibility for the next 15 months.
Virgo Global Ltd reported revenue from operations of ₹0.9 Cr and net profit of ₹0.8 Cr (+33.3% YoY) for Q4 FY26.
Virgo Global Ltd reported audited financial results for the year ended March 31, 2026. The company also approved a capital reduction scheme to offset accumulated losses against paid-up equity capital. An EGM is scheduled for May 15, 2026, to seek shareholder approval for the restructuring.
Emcure Pharmaceuticals Ltd reported revenue from operations of ₹2,470 Cr (+16.7% YoY) and net profit of ₹243.7 Cr (+23.6% YoY) for Q4 FY26.
Emcure Pharmaceuticals approved its FY26 audited results, reporting consolidated revenue of ₹9,204 Crore and PAT of ₹941 Crore. The board recommended a final dividend of ₹3.60 per share. Key leadership re-appointments include Mr. Satish Mehta as Managing Director for five years and Dr. Mukund Gurjar as Whole-time Director for one year.
Dolphin Offshore Enterprises (India) Ltd reported revenue from operations of ₹45.4 Cr (+122.5% YoY) and net profit of ₹28.3 Cr (+172.1% YoY) for Q4 FY26.
Dolphin Offshore Enterprises (India) Limited reported its audited financial results for FY2026. Standalone annual revenue stood at ₹11.73 Crore with a net profit of ₹37.54 Crore. Consolidated annual revenue reached ₹116.42 Crore with a net profit of ₹68.54 Crore. The Board also re-appointed M/s. Manubhai & Shah LLP as internal auditors for FY2026-27.